Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Scientific Reports|February 7, 2018
Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASHKumiko Shiba, Kyoichiro Tsuchiya, Chikara Komiya, et al.
Biochemical and Biophysical Research Communications|August 10, 2020
Blocking sphingosine 1-phosphate receptor 2 accelerates hepatocellular carcinoma progression in a mouse model of NASHTomoaki Yoshida, Atsunori Tsuchiya, Masaru Kumagai, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 4, 2006
Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophagesTakayoshi Suganami, Kanami Tanimoto-Koyama, Junko Nishida, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 25, 2008
In vivo and in vitro inhibition of monocyte adhesion to endothelial cells and endothelial adhesion molecules by eicosapentaenoic acidHideto Yamada, Masayuki Yoshida, Yasutaka Nakano, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 16, 2007
Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjectsMichiko Itoh, Takayoshi Suganami, Noriko Satoh, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 24, 2021
The sodium-glucose cotransporter-2 inhibitor Tofogliflozin prevents the progression of nonalcoholic steatohepatitis-associated liver tumors in a novel murine modelNaoki Yoshioka, Miyako Tanaka, Kozue Ochi, et al.
Plos One|December 19, 2013
Hepatic crown-like structure: a unique histological feature in non-alcoholic steatohepatitis in mice and humansMichiko Itoh, Hideaki Kato, Takayoshi Suganami, et al.
JCI Insight|December 5, 2017
CD11c+ resident macrophages drive hepatocyte death-triggered liver fibrosis in a murine model of nonalcoholic steatohepatitisMichiko Itoh, Takayoshi Suganami, Hideaki Kato, et al.
Scientific Reports|March 18, 2017
Antifibrotic effect of pirfenidone in a mouse model of human nonalcoholic steatohepatitisChikara Komiya, Miyako Tanaka, Kyoichiro Tsuchiya, et al.
Scientific Reports|December 22, 2019
Upregulation of cancer-associated gene expression in activated fibroblasts in a mouse model of non-alcoholic steatohepatitisMasahiro Asakawa, Michiko Itoh, Takayoshi Suganami, et al.
Pageof 4